The Venture Codex Logo

The Venture Codex

Sailing Capital

34/F, Tower 1, Times Square, 1 Matheson Street, Causeway Bay, Hong Kong

Overview

Founded in 2012, Sailing Capital (“Sailing”) is the first major private equity fund on the global stage with its initial capital raised domestically in Chinese Yuan (RMB). Sailing was initiated by Shanghai International Group (SIG) mainly for investment overseas. Their LPs include some of the most successful and influential companies in China. Their underlying fund size is currently set to reach RMB 50 billion (US$ 8 billion) and They have successfully completed Their first round of fundraising of RMB 12 billion (US$ 1.9 billion). Sailing engages in direct investment and intends to establish industry-specific or geography-specific sub-funds to manage jointly with the key co-investor(s) in each. Sailing’s commitments can take the form of equity, equity-linked, mezzanine and/or debt capital contributed on a full acquisition, majority or minority basis. Sailing enjoys the flexibility to invest in a wide range of geographies and industry sectors. Their multinational and experienced team possesses a variety of backgrounds in and outside of China, including Wall Street’s bulge bracket, the international legal community, blue chip conglomerates and the Big Four accountancies.

Total investments
8
Lead investments
3
Investments · 12mo
0
Active investors
0

Sector focus

  • Financial Services
Visit website

Investment portfolio

  • Impossible Foods

    Participated · Series E · May 2019

    Impossible Foods develops plant-based meat and dairy alternatives intended to compete directly with animal-based products while dramatically reducing greenhouse gas emissions. Its flagship product is the Impossible Burger and the company has recently expanded its portfolio with items such as Impossible Sausage, Chicken Nuggets, Pork, and Meatballs. The company reports rapid retail growth—products are now in about 22,000 grocery stores (up from 150 in March 2020) and in close to 40,000 restaurants globally—and says it is the fastest-growing plant-based meat company in retail per custom IRI research. Over the past 14 months it has entered four new international markets, including Canada, the United Arab Emirates, Australia and New Zealand, and it is pursuing further international expansion. Impossible Foods plans to use capital to accelerate retail presence, strengthen its supply chain, expand its product portfolio, and develop its technology platforms in support of its climate-focused mission. Since its founding in 2011 the privately held company has raised close to $2 billion. Impossible Foods develops plant‑based meat and dairy alternatives, best known for the Impossible Burger and the recently launched Impossible Sausage. The company plans to expand research and development, accelerate manufacturing scale‑up, grow retail presence and availability in key international markets, and commercialize next‑generation products such as Impossible Pork, plant‑based milk and steak. Impossible Foods secured $200 million in a Series G led by Coatue and has raised about $1.5 billion since its 2011 founding. Its flagship Impossible Burger is available in more than 8,000 grocery stores across all 50 states, and Impossible Sausage reached over 22,000 restaurants within six months of launch. The company launched direct‑to‑consumer e‑commerce with two‑day delivery and reports roughly 95% online customer satisfaction, while reporting dramatic increases in production capacity with no COVID‑19 manufacturing disruptions. Impossible Foods develops plant-based meat and dairy products, best known for the Impossible Burger, and has launched next-generation items including Impossible Sausage and Impossible Pork. The company plans to invest in fundamental research and innovation, accelerate manufacturing scaleup, expand retail presence and availability in key international markets, and commercialize its next-generation products. It has expanded production dramatically—more than quadrupling output at its Oakland facility—and lowered prices to U.S. foodservice distributors by about 15% on average. The company emphasizes scaling to meet global demand and has implemented extensive employee health and safety measures during the COVID-19 pandemic. Impossible Foods has raised significant outside capital to fund growth and operations and frames these investments as critical to achieving its 2035 mission to replace animal-based food production. Impossible Foods develops plant-based meat substitutes, most notably the Impossible Burger. The company has concentrated on restaurants and business-to-business sales rather than retail grocery, a strategy highlighted by the nationwide rollout of the Impossible Whopper with Burger King. The Impossible Burger is sold in more than 7,000 restaurants across the U.S. and Europe. The company reported strong sales growth in Asia, including Hong Kong, Singapore and Macau. Financially, the company completed a $300 million financing that brought its total equity raised to $750 million. Impossible Foods is hiring extensively at its largest plant in Oakland, Calif., and has added senior operations leadership following the new funding. Impossible Foods develops plant-based meat and dairy products using modern science; its flagship product is the Impossible Burger. The company genetically engineers yeast to produce heme (soy leghemoglobin), a key molecule that gives the burger its meat-like taste, and the product is made from ingredients including water, wheat protein, potato protein and coconut oil. The Impossible Burger is now available in more than 1,000 restaurants across the U.S., and the company is moving from premium outlets into more mainstream channels. Impossible Foods began ramping its first large-scale production facility in September 2017 and plans to add a second shift in its Oakland plant to meet demand. The company recently raised convertible financing and has disclosed approximately $214 million raised in the past 18 months and about $396 million in total venture funding since founding. Management says much of the recent financing is convertible debt that it expects can convert to equity at a higher future valuation as the company scales and expands internationally.

  • Ola

    Led · Equity · Sep 2018

    Ola is a ride‑hailing platform that operates in India as well as Australia, the U.K. and New Zealand and reports over a million drivers on its platform. The company has been raising capital ahead of plans to file for an initial public offering early next year. In a recent filing Ola disclosed a $139 million investment tranche that values the company at about $7.3 billion. Five months earlier Ola raised $500 million in a round led by Temasek and Warburg Pincus, into which CEO Bhavish Aggarwal also invested. The business said its ride‑hailing operations rebounded after New Delhi eased COVID restrictions, but the company and its spun‑out unit Ola Electric have faced product delays, executive departures and competitive pressure. Ola Electric, which spun out in 2019, has also been raising capital and unveiled electric scooters that have seen delayed deliveries amid chip shortages. Ola is a Bangalore-headquartered ride-hailing platform operating in over 100 cities in India and has expanded to Australia, New Zealand and the U.K. It has amassed over a million driver partners and had about 32 million monthly active Android users in India in June, up from about 26 million in May (Uber had roughly 22 million). The company leads the Indian market and competes directly with Uber. Ola spun out EV business Ola Electric in 2019; that unit is seeking funding and will soon begin production of electric scooters. Mobility firms were hit hard by the coronavirus pandemic, but Ola says it has seen strong recovery post-lockdown and a shift in consumer preference away from public transportation. The company was previously backed by SoftBank and was valued at under $5 billion in its prior financing round. Ola Financial Services (OFS) operates the Ola Money digital payments and financial-services business within Ola. The company aims to build consumer-first, digital-first financial products leveraging Ola's ride-sharing platform reach, per CEO Bhavish Aggarwal. Aggarwal said the financial services space is significantly underserved due to weak distribution, low trust, and complicated products, presenting a "once in a lifetime" opportunity. OFS has raised about Rs 205 crore in its maiden institutional financing round from Matrix Partners and others and was valued at roughly $250 million (about Rs 1,875 crore) according to sources. Leadership at OFS is shifting: head Nitin Gupta has decided to move on and Harish Abhichandani has been named interim CEO. The fundraise and leadership changes come amid broader stress at Ola: the company cut 1,400 jobs and reported a roughly 95% revenue decline over the prior two months due to the COVID-19 pandemic. Ola Electric Mobility was created as a dedicated, independent EV business backed by parent company Ola, which provided founding capital. The unit will focus beyond vehicles on charging solutions, EV batteries and developing infrastructure to enable commercial EV operations at scale. Leadership includes Ola executives Anand Shah and Ankit Jain and former car-maker executives; the team has partnered with “several” OEMs and battery makers. Ola Electric inherits links to Ola’s connected-car platform and intends to work closely with the automotive industry to create seamless electric-vehicle solutions. The company has set ambitious commercial targets: Ola previously pledged to add 10,000 electric rickshaws and had a goal of one million EVs by 2022 as part of its broader electrification efforts. Financially, Ola Electric has just secured early external funding alongside Ola’s founding capital to accelerate its plans. Ola is a ride-hailing company founded in 2010 that offers transport services across more than 100 Indian cities and has expanded internationally to Australia, New Zealand and the U.K. Beyond ride-hailing, Ola operates payments, food delivery and bicycle services and has invested in electric scooters. The company has raised around $3.3 billion from investors to date and recently took in ₹520 crore (about $75 million) from existing investor Steadview Capital. Filings from that investment indicate Ola’s business is valued at roughly $5.7 billion, up from recent lows and higher than a $4.3 billion figure reported last year. Additional deal activity includes a Competition Commission approval for a Temasek-affiliated vehicle to acquire 7% of Ola and a reported SoftBank term sheet for a prospective $1 billion investment. Sources in the article say the ₹520 crore top-up appears to be an early tranche of a larger, sizeable fundraising round that may close in multiple tranches.

  • XGIMI

    Participated · Equity · Mar 2018

    XGimi Technology is a China-based home entertainment technology manufacturer that makes high-definition widescreen projectors. Its projectors can display television programming on walls up to 300 inches and can connect to mobile devices. The company raised more than RMB600m (about $95m) in its latest funding round. Investors in the round included Baidu, Matrix Partners China, Sichuan Culture Industry Equity Investment Fund, Sailing Capital, Bojiang Capital, Pan-Lin Asset Management, Luxin Venture Capital Group and Jirui Capital. Baidu returned in the round and became XGimi's largest external shareholder after having initially invested last year. The articles do not disclose other financial metrics such as revenue or user counts.

  • Cellular Biomedicine Group

    Led · Equity · Feb 2018

    Cellular Biomedicine Group (CBMG) is a US-China biopharmaceutical firm. According to a CBMG company release reported in the article, Shanghai- and Hong Kong-based private equity firm Sailing Capital Overseas Investment and its affiliates invested $30.6 million in CBMG. The article reports the investment amount as $30.6 million. The report does not specify the instrument (equity, debt, etc.) or the intended use of the funds. No revenue, user metrics, past financing rounds, founding year, or additional financial details were provided in the article. All information here is drawn from the cited company release as reported in the article.

  • SenseTime

    Participated · Series B · Dec 2017

    SenseTime Medical is the healthcare subsidiary of SenseTime focused on applying the group’s AI expertise to hospital operations and clinical care. Its core assets include the "DaYi" medical large language model—trained on large-scale, high-quality medical data—and a multimodal medical imaging foundation model suite that handles radiology, pathology and other image types with small-sample and weak-label training. These engines underpin a broad product matrix spanning diagnosis, decision support, patient services and research, enabling hospitals to deploy interoperable AI modules rather than multiple point solutions. Institutions such as Macau’s Kiang Wu Hospital have adopted more than ten of the company’s AI products. Operating independently under SenseTime’s “1+X” strategy since 2018, the company pursues a dual approach of large smart-hospital contracts and standardized modules for lower-tier facilities. It has initiated a Series A raise at a post-money valuation above RMB 3 billion (≈US$420 million). The articles did not disclose revenue or user metrics.

Team

No current team members are available.